Adicet Bio, Inc. Fair Value Adjustment of Warrants
Adicet Bio, Inc. (ACET) reported Fair Value Adjustment of Warrants of $897.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2022-03-15
- Adicet Bio, Inc. fair value adjustment of warrants for the quarter ending 2020-12-31 was $0.00.
- Adicet Bio, Inc. fair value adjustment of warrants for the quarter ending 2020-09-30 was $954.00K.
- Adicet Bio, Inc. fair value adjustment of warrants for the quarter ending 2020-06-30 was $13.00K.
- Adicet Bio, Inc. fair value adjustment of warrants for the quarter ending 2020-03-31 was -$70.00K.
- Adicet Bio, Inc. fair value adjustment of warrants for fiscal 2020 was $897.00K.
- Adicet Bio, Inc. fair value adjustment of warrants for fiscal 2019 was -$250.00K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $954.00K derived: sum of 2 quarters · filed 2022-03-15 | $967.00K derived: sum of 3 quarters · filed 2022-03-15 | $897.00K 10-K · filed 2022-03-15 |
| 2020-09-30 | $954.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $967.00K derived: sum of 2 quarters · filed 2021-11-10 | $897.00K 10-Q · filed 2021-11-10 | $709.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$57.00K 10-Q · filed 2021-08-12 | -$245.00K derived: sum of 3 quarters · filed 2021-08-12 | |
| 2020-03-31 | -$70.00K 10-Q · filed 2021-05-17 | -$258.00K derived: sum of 2 quarters · filed 2021-05-17 | ||
| 2019-12-31 | -$188.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$250.00K 10-K · filed 2021-03-12 | ||
| 2019-09-30 | -$62.00K 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |